旺旺(00151.HK):料疫症爆發對2月及3月業務營運及財務表現產生不利影響
中國旺旺(00151.HK)公布,自疫症爆發以來,中國的有關部門已採取了緊急的公共衛生措施,包括延長中國農曆新年假期及實施旅行限制和其他與工作相關的限制。
自2020年2月10日起,集團的大部分生產設施及銷售分公司已陸續取得了政府批准及逐步恢復營運。然而,由於在某些地區(包括湖北省地區)交通運輸的暫停或僅提供有限度的服務,集團仍未回復其正常的營運水平,從而將會影響到集團短時間的銷售。
有鑒於上述,董事會預計就於2020年3月31日結束的財政年度,疫症的爆發可能會對集團2020年2月(中國農曆新年後)及3月時期的業務營運及財務表現產生不利的影響,但目前對實際影響進行量化仍太早。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.